CV Sciences, Inc.
USD0.02
+0.00 (+10.00%)
CEO
Joseph D. Dowling
IPO Date
2013-02-12
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
OTC
Country
US
Open
$0.03
Prev. Close
$0.02
Day Low
$0.02
Day High
$0.03
52W Low
$0.02
52W High
$0.10
Market Cap
$0.00B
Volume
0.07M
| -2.5 |
| 31 Dec 2023 | FY | 44.3% | 19.4% | 106.9% | 11.8% | 0.15 | 1.30 | 1.8 |
| 31 Dec 2022 | FY | 34.2% | -50.7% | 1057.1% | -64.5% | -1.97 | 0.84 | -0.5 |
| 31 Dec 2021 | FY | 43.0% | -77.6% | -439.0% | -86.1% | 0.26 | 0.98 | -0.8 |
| 31 Dec 2020 | FY | 45.1% | -91.2% | -198.8% | -72.8% | 0.69 | 1.18 | -2.1 |
| 31 Dec 2019 | FY | 65.3% | -30.9% | -57.0% | -31.5% | 0.35 | 2.45 | -5.7 |
| 31 Dec 2018 | FY | 70.2% | 20.7% | 33.2% | 27.1% | 0.02 | 5.80 | 47.9 |
| 31 Dec 2017 | FY | 70.1% | -23.7% | -29.9% | -21.6% | 0.10 | 2.38 | -10.1 |
| 31 Dec 2016 | FY | 63.3% | -127.9% | -107.1% | -76.1% | 0.20 | 1.53 | -1.6 |
| -13.7 |
| 30 Sept 2025 | Q3 | 48.5% | -11.7% | -24.8% | -5.5% | 0.56 | 1.06 | -5.1 |
| 30 Jun 2025 | Q2 | 50.9% | -7.2% | -14.5% | -3.3% | 0.94 | 1.04 | -6.5 |
| 31 Mar 2025 | Q1 | 46.0% | -3.0% | -5.8% | -1.4% | 0.80 | 1.14 | -13.7 |
| 31 Dec 2024 | Q4 | 43.2% | -18.7% | -40.4% | -9.2% | 0.43 | 1.02 | -2.1 |
| 30 Sept 2024 | Q3 | 46.0% | -11.8% | -20.8% | -5.4% | 0.38 | 1.10 | -4.6 |
| 30 Jun 2024 | Q2 | 47.0% | -14.8% | -23.3% | -6.6% | 0.20 | 1.12 | -3.8 |
| 31 Mar 2024 | Q1 | 46.3% | -15.7% | -26.6% | -7.4% | 0.12 | 1.23 | -2.5 |
| 31 Dec 2023 | Q4 | 45.8% | -22.9% | -29.9% | -3.3% | 0.15 | 1.30 | -1.6 |